Results 61 to 70 of about 1,008 (88)

Targeted radionuclide therapy and diagnostic imaging of SSTR positive neuroendocrine tumors: a clinical update in the new decade. [PDF]

Front Nucl Med
Haugh KN, Sanwick AM, Chaple IF.
europepmc   +1 more source

FAPI Dimerization for Theranostic Applications: Molecular Design, Preclinical Validation, and Clinical Translation. [PDF]

Chem Biomed Imaging
Jiang P, Shao K, Zhu B, Chen F.
europepmc   +1 more source

Recommendations for selection, treatment, and follow-up in peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors: a Delphi consensus from the Galician Multidisciplinary Group on Neuroendocrine and Endocrine Tumors (GGNET). [PDF]

Clin Transl Oncol
Martinez-Lago N, Cabezas Agricola JM, Anido Herranz U, Nogareda Seoane Z, Cousillas Castiñeiras A, Varela Ponte R, Fernández Catalina P, Abou Jokh Casas E, de Matías Leralta JM, Pubul Nuñez V.   +9 more
europepmc   +1 more source

Linker Chemistry in Radiopharmaceutical Design. [PDF]

Bioconjug Chem
Stoddard A, Furey K, Dehlavi G, Mane MM, Sebastiano J, Zeglis BM.   +5 more
europepmc   +1 more source

Blood-based transcriptomic biomarkers for response to [¹⁷⁷Lu]Lu-DOTA-TATE therapy in neuroendocrine tumors. [PDF]

EJNMMI Res
Sung H, Bae S, Suh M, Choi H, Im HJ, Cheon GJ, Kang KW.   +6 more
europepmc   +1 more source

The evolving role of targeted radioligand therapy in small cell and non-small cell lung cancer: a systematic review. [PDF]

Explor Target Antitumor Ther
Moghrabi S, Ruzzeh S, Al-Rabi K, Abdlkadir A, Al-Jaghbeer MJ, Alzorgan N, Rasheed UA, Alqudah M, Al-Ibraheem A.   +8 more
europepmc   +1 more source

Assessment of Early Cardiotoxicity and Cardiac Dysfunction of Radioligand Therapy in Patients with Neuroendocrine Tumors. [PDF]

Cancers (Basel)
Jóźwik-Plebanek K, Saracyn M, Kołodziej M, Mądra W, Durma AD, Dziuk M, Balcerska Z, Janiak K, Gniadek-Olejniczak K, Kamiński G.   +9 more
europepmc   +1 more source

Multifactorial analysis of radiochemical purity in high-activity ¹⁷⁷Lu-labeled theranostics: impact of precursor source, ¹⁷⁷Lu form, and production parameters. [PDF]

EJNMMI Radiopharm Chem
Hunt W, Long M, Kamil U, Kellapatha S, Noonan W, Roselt PD, Papa N, Emmerson B, Hofman MS, Haskali MB.   +9 more
europepmc   +1 more source

Preclinical evaluation of [225Ac]Ac-DOTA-TATE for treatment of lung neuroendocrine neoplasms

European Journal of Nuclear Medicine and Molecular Imaging, 2021
Darpan Pandya, Zhen Wang, Narges Tafreshi   +2 more
exaly